A breath of fresh air for acute oxygen treatment.

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 2003;123:1480–7. 23. Löfdahl C-G, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ 1999;319:87–90. 24. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008;63(Suppl IV):iv1–121. 25. Harrald LR, Patterson MK, Andrade SE, et al. Asthma drug use and the development of Churg– Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf 2007;16:620–6. 26. Bili A, Condemi JJ, Bottone SM, et al. Seven cases of complete and incomplete forms of Churg–Strauss syndrome not related to leukotriene receptor antagonists. J Allergy Clin Immunol 1999;104:1060–5. 27. Le Gall C, Pham S, Vignes S, et al. Inhaled corticosteroids and Churg–Strauss syndrome: a report of five cases. Eur Respir J 2000;15:978–81. 28. Solans R, Bosch JA, Selva A, et al. Montelukast and Churg–Strauss syndrome. Thorax 2002;57:183–5. 29. Nathani N, Little MA, Kunst H, et al. Churg–Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Thorax 2008;63:883–8. 30. Hauser T, Mahr A, Metzler C, et al. The leukotriene receptor antagonist montelukast and the risk of Churg–Strauss syndrome: a case crossover study. Thorax 2008;63:677–82. 31. Weller PF, Plaut M, Taggart V, et al. The relationship of asthma therapy and Churg–Strauss syndrome: NIH workshop summary report. J Allergy Clin Imunol 2001;108:175–83.